Start a confidential scoping conversation
For confidential biotech, spinout, investor, or strategic diligence inquiries, the best first step is a brief scoping conversation about the decision you are facing.
How to begin
Bring one decision. Best fit: a concrete scientific-strategic question — for example, whether a platform claim is defensible, which experiment would most change the story, what biomarkers belong in a first trial, or how to position an asset before partnering, financing, or diligence.
Share the question, the decision context, and the rough timeline. Every engagement starts with a written scope — defining sources, assumptions, confidentiality, and a clear, decision-ready deliverable — before any work begins.
Prefer email? [email protected]
Scoped & confidential. Inquiries are treated in confidence. Engagements are defined in writing and organized around a clear deliverable rather than open-ended hours.
Ready when you are
For confidential biotech, spinout, investor, or strategic diligence inquiries, start with a brief scoping conversation.
Request a confidential scoping callPrefer email? [email protected]